BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17651449)

  • 21. Molecular epidemiology and clinical implications of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from urine.
    Sako S; Kariyama R; Mitsuhata R; Yamamoto M; Wada K; Ishii A; Uehara S; Kokeguchi S; Kusano N; Kumon H
    Acta Med Okayama; 2014; 68(2):89-99. PubMed ID: 24743784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
    Er H; Altındiş M; Aşık G; Demir C
    Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of metallo-β-lactamase IMP-14 and VIM-2 in Pseudomonas aeruginosa clinical isolates from a tertiary-level hospital in Thailand.
    Piyakul C; Tiyawisutsri R; Boonbumrung K
    Epidemiol Infect; 2012 Mar; 140(3):539-41. PubMed ID: 21733273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impact of dissemination of metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa in hospitals: present and future].
    Oliver A
    Enferm Infecc Microbiol Clin; 2009 May; 27(5):255-6. PubMed ID: 19361889
    [No Abstract]   [Full Text] [Related]  

  • 26. Emergence of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in a paediatric hospital in Serbia.
    Jovcic B; Vasiljevic Z; Djukic S; Topisirovic L; Kojic M
    J Med Microbiol; 2011 Jun; 60(Pt 6):868-869. PubMed ID: 21330409
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in central Pakistan.
    Saleem S; Bokhari H
    J Infect Public Health; 2020 Apr; 13(4):598-605. PubMed ID: 31564530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals.
    Glupczynski Y; Bogaerts P; Deplano A; Berhin C; Huang TD; Van Eldere J; Rodriguez-Villalobos H
    J Antimicrob Chemother; 2010 May; 65(5):866-71. PubMed ID: 20200037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
    Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa in a Healthcare Setting in Alexandria, Egypt.
    Abaza AF; El Shazly SA; Selim HSA; Aly GSA
    Pol J Microbiol; 2017 Sep; 66(3):297-308. PubMed ID: 29319510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.
    Zavascki AP; Goldani LZ; Gonçalves AL; Martins AF; Barth AL
    Epidemiol Infect; 2007 Feb; 135(2):343-5. PubMed ID: 16824253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
    Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
    J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of metallo-β-lactamase-producing Pseudomonas aeruginosa in a Czech hospital (2009-2011).
    Papagiannitsis CC; Studentova V; Ruzicka F; Tejkalova R; Hrabak J
    J Med Microbiol; 2013 Jun; 62(Pt 6):945-947. PubMed ID: 23493029
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan.
    Mano Y; Saga T; Ishii Y; Yoshizumi A; Bonomo RA; Yamaguchi K; Tateda K
    BMC Microbiol; 2015 Feb; 15():41. PubMed ID: 25881168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
    Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
    Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of β-lactamases in Pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals.
    Ktari S; Mnif B; Znazen A; Rekik M; Mezghani S; Mahjoubi-Rhimi F; Hammami A
    Microb Drug Resist; 2011 Mar; 17(1):25-30. PubMed ID: 21190476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. bla(VIM-2) cassette-containing novel integrons in metallo-beta-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital.
    Lee K; Lim JB; Yum JH; Yong D; Chong Y; Kim JM; Livermore DM
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1053-8. PubMed ID: 11897589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.